CoRegen, Inc. — Form D

CoRegen, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-28. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Lee C Fleisher, M.D.DirectorAspen, CO
Steve C GorlinDirectorAspen, CO
William C Haseltine, PhD.DirectorAspen, CO
Shawn C TomaselloDirectorAspen, CO
David C Lonard, PhDExecutive OfficerAspen, CO
John C Thomas, Jr.Executive OfficerAspen, CO
Shawn C TomaselloExecutive OfficerAspen, CO
Lee J Fleisher, M.D.DirectorAspen, CO
John Thomas, Jr.Executive OfficerAspen, CO
Jonathan W SimonsDirectorAspen, CO
William J Haseltine, PhD.DirectorAspen, CO
Edward J Benz, Jr.DirectorAspen, CO
David Lonard, PhDExecutive OfficerAspen, CO
Suneet J VarmaDirectorAspen, CO
Steve GorlinDirectorDestin, FL
Steve GorlinExecutive OfficerDestin, FL
Clifford C Dasco, M.D.DirectorAspen, CO
Clifford C Dasco, M.D.Executive OfficerAspen, CO
Bert W O'MalleyDirectorAspen, CO
Steve C GorlinExecutive OfficerAspen, CO
David M Cornell, IIDirectorAspen, CO
Bert W O'Malley, M.D.DirectorAspen, CO
Sonal GuptaExecutive OfficerHouston, TX
Jonathan W. SimonsDirectorHouston, TX
Bert W. O'MalleyDirectorHouston, TX

Other filings by this issuer (5)

FiledFormOfferingSold
2026-02-26D$13.5M$13.5M
2025-05-22D$62.6M$62.6M
2025-02-28D$20.8M$20.8M
2024-03-08D$12.9M$12.9M
2024-02-22D$14.5M

More